Department of Genetics and Genomic Sciences at Mount Sinai researchers are uncovering how microglia—immune cells in the brain—contribute to Alzheimer’s disease. Led by Alison Goate, DPhil, the team identified genes and regulators tied to disease-associated microglia, offering new targets for therapies that may enhance brain protection and complement existing treatments.